Loading...
XNAS
RDGT
Market cap6mUSD
Jul 11, Last price  
1.06USD
1D
-10.92%
1Q
3.92%
IPO
-26.39%
Name

China Jo-Jo Drugstores Inc

Chart & Performance

D1W1MN
P/E
P/S
0.04
EPS
Div Yield, %
Shrs. gr., 5y
-9.74%
Rev. gr., 5y
7.52%
Revenues
155m
+3.85%
0055,174,92969,969,47994,352,88589,495,54666,154,58776,895,73289,065,58081,499,04596,112,706107,551,012117,327,689133,134,633164,392,555148,811,976154,541,077
Net income
-4m
L-79.97%
-3,737-28,7489,821,7418,432,4588,141,626-14,333,731-25,356,136856,557447,156-5,644,204-17,059,933-1,317,769-6,457,677-8,375,578-3,198,366-21,138,777-4,234,228
CFO
-3m
L-3.90%
-3,737-28,748807,309-5,183,74819,967,243-313,340684,1161,063,2182,585,7051,559,502-2,070,066-5,603,216-6,907,945-62,292-5,385,972-3,283,513-3,155,439

Profile

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.
IPO date
Apr 14, 2008
Employees
885
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
154,541
3.85%
148,812
-9.48%
Cost of revenue
158,076
159,377
Unusual Expense (Income)
NOPBT
(3,535)
(10,565)
NOPBT Margin
Operating Taxes
63
395
Tax Rate
NOPAT
(3,597)
(10,960)
Net income
(4,234)
-79.97%
(21,139)
560.92%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,590
7,325
BB yield
-56.92%
-320.71%
Debt
Debt current
37,070
34,387
Long-term debt
17,670
20,668
Deferred revenue
Other long-term liabilities
Net debt
33,395
34,475
Cash flow
Cash from operating activities
(3,155)
(3,284)
CAPEX
(857)
(312)
Cash from investing activities
(2,040)
(316)
Cash from financing activities
8,004
2,366
FCF
(3,249)
(19,086)
Balance
Cash
20,150
18,808
Long term investments
1,195
1,772
Excess cash
13,618
13,139
Stockholders' equity
(72,121)
(67,291)
Invested Capital
130,141
124,115
ROIC
ROCE
EV
Common stock shares outstanding
1,444
510
Price
3.15
-29.69%
4.48
17.70%
Market cap
4,549
99.18%
2,284
4,039.12%
EV
36,598
35,412
EBITDA
1,850
(9,847)
EV/EBITDA
19.78
Interest
14
66
Interest/NOPBT